Skip to content

Impact of dynamic liver function on long-term outcome after curative liver function for HCC

Impact of dynamic liver function on long-term outcome after curative liver function for HCC - HCC_2016

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00017412
Enrollment
146
Registered
2019-06-11
Start date
2016-01-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C22.0

Interventions

Group 1: Evaluation of preoperative (clinical, laboratory, pathological parameters, dynamic liver function) and intraoperative predictors for long-term survival and recurrence.

Sponsors

Charité - Universitätsmedizin Berlin Chirurgische Klinik Campus Charité Mitte l Campus Virchow-Klinikum
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. patients with first diagnosis HCC without extrahepatic metastases who habe undergone curative liver resection 2. Age 18-100 years 3. patients with at least one dynamic liver functions test (LiMAx-Test, ICG-PDR)

Exclusion criteria

Exclusion criteria: 1. Patient who had liver resection before with significant impact on liver function 2. Patients with cancer apart from HCC 3. Patients who received preoperative treatment with significant impact on liver function (e.g. chemotherapy) 4. intraoperative additional therapy except liver resection

Design outcomes

Primary

MeasureTime frame
The aim of this study was to investigate the impact of preoperative dynamic liver function on long-term outcome.

Countries

Germany

Contacts

Public ContactElisabeth Blüthner

Charité - Universitätsmedizin Berlin

elisabeth.bluethner@charite.de010450665209

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026